This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schrappe M, Arico M, Harbott J, Biondi A, Zimmermann M, Conter V et al. Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome. Blood 1998; 92: 2730–2741.
Cazzaniga G, Lanciotti M, Rossi V, Di Martino D, Arico M, Valsecchi MG et al. Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response. Br J Haematol 2002; 19: 445–453.
Secker-Walker LM, Prentice HG, Durrant J, Richards S, Hall E, Harrison G . Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party. Br J Haematol 1997; 96: 601–610.
Radich JP . Philadelphia chromosome-positive acute lymphocytic leukemia. Hematol Oncol Clin North Am 2001; 15: 21–36.
Arico M, Valsecchi MG, Camitta B, Schrappe M, Chessells J, Baruchel A et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 2000; 342: 998–1006.
Bassan R, Rohatiner AZ, Lerede T, Di Bona E, Rambaldi A, Pogliani E et al. Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemia. Hematol J 2000; 1: 226–234.
Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cells 2002; 1: 133–143.
Hofmann WK, de Vos S, Elashoff D, Gschaidmeier H, Hoelzer D, Koeffler HP et al. Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene expression profiles: a gene-expression study. Lancet 2002; 359: 481–486.
Acknowledgements
This work was supported in part by grants from Fondazione M. Tettamanti, Associazione Paolo Belli, Fondazione ‘Città della Speranza’, Fondazione Cariplo, Associazione Italiana per la Ricerca sul Cancro (AIRC), CNR-MIUR Progetto Strategico Oncologia, Progetto Finalizzato RF00-368 IRCCS ‘Casa Sollievo della Sofferenza’ (SG Rotondo, Italy) and Conselho Nacional de Desenvolvimento Tecnologico (CNPq-Brazil). We thank Monica Spinelli (Padova) and Orietta Spinelli (Bergamo) for technical work, D Silvestri (Monza) for statistical assistance and Joanna Upton for her critical review of the language. We thank all investigators from AIEOP Institutions, who provided patient samples.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scrideli, C., Cazzaniga, G., Fazio, G. et al. Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia. Leukemia 17, 2234–2237 (2003). https://doi.org/10.1038/sj.leu.2403110
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403110
This article is cited by
-
Prognostic significance of co-overexpression of the EGFR/IGFBP-2/HIF-2A genes in astrocytomas
Journal of Neuro-Oncology (2007)
-
Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop
Leukemia (2004)